JPMorgan Chase & Co. boosted its position in ProAssurance Co. (NYSE:PRA - Free Report) by 34.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 253,175 shares of the insurance provider's stock after purchasing an additional 65,325 shares during the period. JPMorgan Chase & Co. owned about 0.49% of ProAssurance worth $3,808,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Point72 Hong Kong Ltd bought a new position in shares of ProAssurance during the 2nd quarter valued at approximately $28,000. nVerses Capital LLC purchased a new stake in ProAssurance during the third quarter worth $44,000. Point72 Asia Singapore Pte. Ltd. boosted its position in ProAssurance by 94.3% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 8,347 shares of the insurance provider's stock valued at $126,000 after purchasing an additional 4,052 shares in the last quarter. FMR LLC raised its stake in shares of ProAssurance by 197.8% during the 3rd quarter. FMR LLC now owns 12,063 shares of the insurance provider's stock worth $181,000 after acquiring an additional 8,012 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC acquired a new stake in shares of ProAssurance in the 2nd quarter worth $166,000. Hedge funds and other institutional investors own 85.58% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have weighed in on PRA shares. StockNews.com raised ProAssurance from a "hold" rating to a "buy" rating in a report on Thursday, December 26th. Piper Sandler downgraded shares of ProAssurance from an "overweight" rating to a "neutral" rating and set a $18.00 price objective on the stock. in a report on Monday, November 11th. Finally, Truist Financial raised their price objective on ProAssurance from $14.00 to $18.00 and gave the company a "hold" rating in a report on Tuesday, November 12th.
Check Out Our Latest Report on PRA
ProAssurance Stock Up 0.3 %
Shares of PRA stock traded up $0.04 on Friday, reaching $15.29. 159,574 shares of the stock were exchanged, compared to its average volume of 201,456. ProAssurance Co. has a twelve month low of $10.76 and a twelve month high of $17.79. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.35. The company has a market capitalization of $782.18 million, a price-to-earnings ratio of 18.42 and a beta of 0.29. The business's 50 day moving average price is $16.17 and its 200 day moving average price is $14.45.
ProAssurance Company Profile
(
Free Report)
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Featured Articles
Before you consider ProAssurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProAssurance wasn't on the list.
While ProAssurance currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
